| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Synergy CHC Corp.
$0.1
-0.02 (-14.02%)
Market Cap
1.57 M
EPS
-1.06
P/E Ratio
-
Value Trade
23.75 K
0.3 %
Week
-45.47 %
1 Month
-60.78 %
3 Month
-93.15 %
6 Month
-94.86 %
5 Year
-83.79 %
All Time
Cash Data
Cash Position
-
Monthly Burn
-
Runway
-
Overview
Volume
1.22 M
52 Week Range
0.09 - 3.18
% held by Insiders
42.99 %
% held by Institutions
4.51 %
Enterprise Value
26.14 M
Total Shares
15.08 M
Short %
1.37 %
Float Shares
8.13 M
Company Description
locked
Upcoming Catalyst
Catalyst Timeline
Dated clinical, regulatory & corporate events for Synergy CHC Corp.
98Total events
2Upcoming
18Tier-1 (high impact)
2015 – 2026Coverage
Upcoming catalysts 2
TBD
T2Timing Guidance
Subscribe to view catalyst details
TBD
T2Product Launch
Subscribe to view catalyst details
Event history 2
TBD
●Quarterly UpdateCorporate
Subscribe to view catalyst details
TBD
◆ATM ProgramCorporate
Subscribe to view catalyst details
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
SNYR Clinical Trial Results & History
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in SNYR
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
SNYR Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
SNYR▼ -14%today
Synergy CHC Corp. Announces Receipt of Nasdaq Letter
Synergy CHC Corp. received a notice from Nasdaq indicating non-compliance with listing rules due to a delayed filing of its Q2 Form 10-Q. The company has 60 days to submit a compliance plan and may have up to 180 days to regain compliance. The notice does not affect the trading of its stock at this time.
Read more →SNYR▼ -8.4%on this news
Synergy CHC Corp. Reports First Quarter 2026 Financial Results
Synergy CHC Corp. reported its financial results for Q1 2026, revealing a revenue decline to $5.49 million from $8.17 million in Q1 2025. The company noted strong growth in its functional beverage segment, which generated over $650,000 in revenue. However, overall net loss increased to $2.57 million, influenced by the absence of prior license revenue and higher operational costs. Despite these challenges, Synergy remains optimistic about future growth opportunities.
Read more →SNYR▼ -20.9%on this news· ran to -48% by day 3
Synergy CHC Corp. Reports Fourth Quarter and Full Year 2025 Financial Results
Synergy CHC Corp. reported its financial results for Q4 and the full year 2025, showing a decline in revenue and increased losses compared to the previous year. Despite these challenges, the company is optimistic about 2026, citing new distribution partnerships and early revenue growth. However, the cancellation of a licensing agreement due to regional instability poses risks to future growth.
Read more →SNYRSynergy CHC Corp. Announces Date Change of Fourth Quarter and Full Year 2025 Earnings and Conference Call
Synergy CHC Corp. has announced a change in the date for its fourth quarter and full year 2025 earnings report, which will now be released on April 1, 2026. The company will also hold a conference call featuring its CEO and CFO to discuss the results. This change highlights the company's ongoing commitment to transparency with investors.
Read more →SNYRSynergy CHC Corp. Announces Fourth Quarter and Full Year 2025 Earnings and Conference Call Information
Synergy CHC Corp. will announce its fourth quarter and full year 2025 financial results on March 31, 2026. The company will host a conference call at 9:00 a.m. ET featuring CEO Jack Ross and CFO Jaime Fickett. Investors can access the call via phone or a live webcast on the company's website.
Read more →SNYRSynergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverage Distribution Across Canada Through Walmart Canada and McKesson Canada
Synergy CHC Corp. is expanding its FOCUSfactor functional beverage line across Canada, partnering with Walmart Canada and McKesson Canada. Starting April 2026, Walmart will introduce four new beverage SKUs, while McKesson will distribute the line nationwide. This move builds on the successful launch of FOCUSfactor supplements and aims to enhance brand presence in both online and in-store channels.
Read more →SNYR▼ -5.6%on this news
Synergy CHC Corp. (NASDAQ: SNYR) Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America
Synergy CHC Corp. has appointed Pedro Colmenares as Director of Sales & Marketing for Mexico and Latin America. This strategic hire comes as the company continues to expand its international presence, with recent shipments of its supplement products to Costco Mexico. Colmenares, who has over 18 years of experience, will lead the commercial strategy and market expansion efforts across the region, capitalizing on his expertise in building scalable commercial platforms. The move aims to strengthen Synergy's market positioning in high-potential Latin American markets.
Read more →SNYR▲ +8.3%on this newsshared move
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor Functional Beverage Distribution with Three New Direct Store Delivery Partners Across Maine and Pennsylvania
Synergy CHC Corp. has announced new Direct Store Delivery partnerships with Pine State Beverage, Fuhrer Beverage Company, and Banko Beverage Co., enhancing the distribution of its FOCUSfactor beverages in Maine and Pennsylvania. This move is part of Synergy's strategy to establish a nationwide distribution network. The partnerships are expected to accelerate the growth of the FOCUSfactor brand in key regions.
Read more →SNYRSynergy CHC Corp. (NASDAQ: SNYR) Adds Five New Direct Store Delivery Partners, Expanding FOCUSfactor Functional Beverage Distribution to Ten States Nationwide
Synergy CHC Corp. has expanded its FOCUSfactor functional beverage distribution by adding five new Direct Store Delivery partners, covering ten states. This rapid growth reflects the company's strategy for national expansion. The new partners include established distributors known for their operational excellence and strong retail relationships, which will help accelerate FOCUSfactor's market presence.
Read more →SNYR▼ -6.4%on this newsshared move
Synergy CHC Corp. Reports Third Quarter 2025 Financial Results and its Eleventh Consecutive Quarter of Profitability
Synergy CHC Corp. reported its financial results for Q3 2025, marking its eleventh consecutive quarter of profitability. The company achieved a revenue increase of 12.4% year-over-year, driven by strategic retail partnerships and a favorable product mix. Despite these gains, net income saw a significant decline compared to the previous year, alongside rising operating expenses. The company remains optimistic about future growth supported by a recent public offering.
Read more →SNYRSynergy CHC Corp Expands FOCUSfactor® Functional Beverage Distribution Across Arkansas Through Partnership with C&M Sales
Synergy CHC Corp has partnered with C&M Sales to enhance the distribution of its FOCUSfactor functional beverages across Arkansas. This partnership aims to leverage C&M Sales' extensive experience and established relationships in the beverage industry to increase visibility and availability of FOCUSfactor products. The collaboration is expected to drive growth in the fast-growing functional beverage market.
Read more →SNYRSynergy CHC Corp. Announces Third Quarter 2025 Earnings and Conference Call Information
Synergy CHC Corp. will announce its third quarter 2025 financial results on November 13, 2025, before market trading. A conference call with CEO Jack Ross and CFO Jaime Fickett will follow at 9:00 a.m. ET. The company is seeing growth in its flagship brands, FOCUSfactor and Flat Tummy, with new market expansions planned.
Read more →SNYRSynergy CHC Corp. (NASDAQ: SNYR) Announces FOCUSfactor® Named #1 Pharmacist Recommended OTC Memory Supplement for 2025-2026
Synergy CHC Corp. announced that its FOCUSfactor® brand has been named the #1 Pharmacist Recommended OTC Memory Supplement for 2025-2026, according to Pharmacy Times. This recognition highlights the brand's commitment to brain health and consumer trust. The company aims to expand its offerings in various retail channels, leveraging its established reputation in the market.
Read more →SNYR▲ +6.3%on this newsshared move
Synergy CHC (NASDAQ: SNYR) Deepens FOCUSfactor® Expansion with Kroger, PriceSmart & Wakefern — Strengthening U.S., Canada, and Global Reach
Synergy CHC Corp. has announced significant retail partnerships with Kroger and Wakefern in the U.S., and Uniprix in Canada, to expand its FOCUSfactor product line. The company is also entering international markets through PriceSmart, enhancing its global reach. This expansion aligns with increasing consumer demand for brain health and clean energy products.
Read more →SNYR▼ -6.1%on this newsshared move
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverages Across New England Through Atlantic Importing Alliance
Synergy CHC Corp. has partnered with Atlantic Importing Company to expand the distribution of its FOCUSfactor® functional beverages across Massachusetts, Connecticut, and Rhode Island. This collaboration aims to enhance consumer access to brain-health products in a rapidly growing market. The partnership is expected to drive significant growth for Synergy CHC in the Northeast, aligning with consumer demand for healthier beverage options.
Read more →SNYR▲ +6.7%on this news
Synergy CHC (NASDAQ: SNYR) Taps Former Coca-Cola Executive to Lead Strategic Partnerships; Appoints Veteran Costco Buyer to Board of Directors
Synergy CHC Corp. has appointed Scott Woodburn as Head of Strategic Partnerships and Teresa Thompson to its Board of Directors. Woodburn, a former Coca-Cola executive, aims to accelerate the expansion of the FOCUSfactor Energy Drink platform. Thompson brings extensive retail experience from Costco, enhancing Synergy's expertise in the vitamins and supplements market.
Read more →SNYRSynergy CHC Corp. (NASDAQ: SNYR) Partners with AlaBev to Launch FOCUSfactor® Beverages in 5,000+ Retail Outlets Across Alabama
Synergy CHC Corp. has partnered with AlaBev to distribute its FOCUSfactor beverages in over 5,000 retail locations across Alabama. This collaboration aims to enhance market penetration in the growing functional beverage sector. The partnership is expected to increase brand awareness and accessibility for consumers seeking cognitive health solutions. Synergy's CEO highlighted the importance of AlaBev's distribution strength in accelerating growth in the region.
Read more →SNYRSynergy CHC Corp. Announces the Closing of its $4.375 Million Public Offering
Synergy CHC Corp. has successfully closed a public offering, raising $4.375 million by selling 1,750,000 shares at $2.50 each. The company has granted underwriters an option to purchase additional shares and issued warrants for future stock purchases. This funding is expected to support the growth of its health and wellness brands.
Read more →SNYR▼ -21.2%on this newsshared move
Synergy CHC Corp. Announces Pricing of $4.375 Million Public Offering
Synergy CHC Corp. has announced the pricing of a public offering of 1,750,000 shares at $2.50 each, aiming to raise $4.375 million. The offering is set to close on August 27, 2025, pending customary conditions. The proceeds will be utilized for working capital and corporate purposes, with underwriters granted an option for additional shares.
Read more →SNYRSynergy CHC Corp to Present at the 2025 Gateway Conference on September 4th
Synergy CHC Corp (SNYR) is confirmed to present at the 2025 Annual Gateway Conference on September 4th in San Francisco, California. The management team will present at 9:30 a.m. PT, with a live webcast available for audiences. Throughout the conference, Synergy executives will also hold one-on-one meetings with potential investors. This event provides a platform for companies to connect with investors and analysts while showcasing their growth and innovation in various sectors.
Read more →SNYRSynergy CHC Corp. (NASDAQ: SNYR) Announces Nationwide EG America Rollout for FOCUSfactor Focus + Energy
Synergy CHC Corp. announced a significant retail distribution agreement with EG America to roll out its FOCUSfactor Focus + Energy beverage across over 1,600 convenience store locations. The partnership is expected to enhance Synergy's market presence in the functional beverage sector, catering to the increasing demand for cognitive health products. CEO Jack Ross highlighted the collaboration as a key strategy to meet the needs of performance-driven consumers. With continued growth and additional distribution developments anticipated, Synergy aims to expand its beverage business further.
Read more →SNYR▼ -8%on this newsshared move
Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability
Synergy CHC Corp. reported its financial results for the second quarter of 2025, marking its tenth consecutive quarter of profitability. Revenue increased to $8.1 million, alongside significant growth in net income and EBITDA compared to the same period last year. The company announced important strategic initiatives, including a new licensing agreement in Turkey and expanded retail distribution across North America. Additionally, Synergy successfully refinanced $20 million of debt, which enhances its financial flexibility.
Read more →SNYRSynergy CHC Corp. Announces Second Quarter 2025 Earnings and Conference Call Information
Synergy CHC Corp. (NASDAQ: SNYR) has announced that it will release its financial results for the second quarter of 2025 on August 14, 2025. This release will be accompanied by a conference call featuring CEO Jack Ross and CFO Jaime Fickett. The event is set to take place before market trading begins, and a live webcast will be available for investors. Synergy CHC is recognized for its consumer health and wellness products, including the popular FOCUSfactor and Flat Tummy brands.
Read more →SNYR▲ +9%on this news
Synergy CHC Corp. (NASDAQ: SNYR) Secures Retail Deals with McKesson Canada and Others as FOCUSfactor Expansion Surges Across North America
Synergy CHC Corp. (NASDAQ: SNYR) has announced significant retail and distribution expansions for its FOCUSfactor supplement and beverage lines across North America. Key partnerships include a national distribution agreement with McKesson Canada and the launch of FOCUSfactor supplements in all London Drugs locations in Western Canada. The company is also set to debut its Focus + Energy beverages at the 2025 ECRM Beverage Show, which will facilitate connections with over 25 national retailers. These strategic moves aim to enhance Synergy's market presence and accelerate growth throughout the region.
Read more →SNYR▲ +17.3%on this news· ran to +33% by day 3
Synergy CHC Corp. (NASDAQ: SNYR) Secures Landmark Retail and Distribution Wins Across North America for FOCUSfactor Supplements and Functional Beverages
Synergy CHC Corp. (NASDAQ: SNYR) announced significant retail and distribution gains for its FOCUSfactor products in North America. The company secured a national item authorization with Core-Mark, allowing its Focus + Energy beverages to reach thousands of locations starting Q3 2025. Additionally, partnerships with Metro Ontario and Energy North Group will enhance the brand's presence in key regions. In a milestone for its international strategy, FOCUSfactor supplements are set to be launched nationally in Walmart Canada by Q4 2025.
Read more →SNYRSynergy CHC (NASDAQ: SNYR) Expands FOCUSfactor to UAE & Turkey — Ignites Global Growth and New Revenue Streams
Synergy CHC Corp. (NASDAQ: SNYR) has expanded its international licensing agreement with Gravity Pharma to include Turkey alongside the UAE for the distribution of its FOCUSfactor brand. This strategic move has resulted in $2 million in upfront licensing revenue and opens additional revenue streams through performance-based royalties. Synergy aims to leverage high-growth markets without diluting ownership or shifting focus from its U.S. operations. The company also highlights the potential of the brain health market, which is expected to exceed $20 billion by 2030, indicating strong future growth prospects.
Read more →SNYRSynergy CHC (NASDAQ: SNYR) Taps Former Coca-Cola Executive to Help Drive FOCUSfactor Energy Drink Global Expansion
Synergy CHC Corp. (NASDAQ: SNYR) has appointed Damian Marano as Vice President of Beverage to spearhead the company's expansion into the functional beverage market. Marano brings over 20 years of experience, notably from Coca-Cola, where he led significant sales and digital initiatives. The launch of FOCUSfactor Energy Drinks, aimed at enhancing mental clarity, aligns with Synergy's strategy to leverage its brand equity in the health and wellness sector. This move is part of a broader initiative to scale their beverage platform across North America and internationally.
Read more →SNYRSynergy CHC Announces New $20 Million Long-Term Credit Facility
Synergy CHC Corp. has announced a $20 million term loan credit agreement with ACP Agency, LLC, set to mature in May 2029. The funds will be used for debt reduction and to support the company's growth initiatives. The loan has a specified interest rate and allows for flexibility through delayed draw provisions. CEO Jack Ross expressed optimism about the refinancing, stating it enhances the company's capital structure and positions it for future strategic goals.
Read more →SNYRSynergy CHC Announces Appointment of Erik Shields as Vice President of Beverage
Synergy CHC Corp. has appointed Erik Shields as Vice President of Beverage, effective May 26, 2025. With nearly 20 years of experience in the beverage industry, Shields is expected to significantly impact Synergy's beverage division as the company expands its flagship product FOCUSfactor into the growing functional beverage market. His role will involve driving go-to-market strategies while aligning with consumer demand for health-oriented options. The appointment comes at a critical time for Synergy as it seeks to innovate and capture growth in this dynamic sector.
Read more →SNYR▲ +10.3%on this news· ran to +23% by day 1
Synergy CHC Corp Reports Growth in Earnings Per Share for its First Quarter 2025 Financial Results and its Ninth Consecutive Quarter of Profitability
Synergy CHC Corp. reported a 30% increase in earnings per share for the first quarter of 2025, marking its ninth consecutive quarter of profitability. The company also expanded its EBITDA margins significantly and plans to enter three new international markets later this year for its FOCUSfactor brand. Although revenues fell 13% year-over-year, the company improved its operations and reduced operating expenses. Synergy is also working on a debt refinancing strategy that is expected to enhance its cash flow and permit further growth initiatives.
Read more →SNYRSynergy CHC Corp. Announces First Quarter 2025 Earnings and Conference Call Information
Synergy CHC Corp. has announced its plans to release financial results for the first quarter of 2025 on May 15, 2025. A conference call will follow the announcement at 9:00 a.m. ET, featuring CEO Jack Ross and CFO Jaime Fickett. Participants can access a live webcast and dial-in details, with a replay available afterward. The company specializes in consumer health care and includes notable brands like FOCUSfactor and Flat Tummy in its portfolio.
Read more →SNYR▼ -19%on this news
Synergy CHC Reports its Eighth Consecutive Quarter of Profitability and its Fourth Quarter and Full Year 2024 Financial Results
Synergy CHC Corp. announced its financial results for Q4 and the full year 2024, marking its eighth consecutive quarter of profitability. Although the company faced challenges such as decreased revenue and net income due to a rebranding of its FOCUSfactor product and retailer de-inventorying, it has successfully executed key initiatives, including expanding partnerships and launching new products. The CEO expressed confidence in future growth as the company enters 2025 with a focus on increasing both top and bottom lines.
Read more →SNYRSynergy CHC Corp. Announces Fourth Quarter and Full Year 2024 Earnings and Conference Call Information
Synergy CHC Corp. (NASDAQ: SNYR) announced that it will release its financial results for the fourth quarter and full year ending December 31, 2024, on March 31, 2025, before market trading begins. In conjunction with this announcement, a conference call will be held at 9:00 a.m. ET, featuring insights from CEO Jack Ross and CFO Jaime Fickett. Investors can access the call through a live webcast on Synergy's website, with a replay available afterward. The company specializes in consumer health care products, notably FOCUSfactor and Flat Tummy.
Read more →SNYR▼ -8.1%on this news
Synergy CHC to Attend 37th Annual ROTH Conference
Synergy CHC Corp. (NASDAQ: SNYR) announced its participation in the 37th Annual ROTH Conference scheduled for March 16-18, 2025, in Dana Point, California. The company aims to engage in one-on-one investor meetings during this event. Synergy is known for its consumer health care and lifestyle products, including the FOCUSfactor supplement and Flat Tummy brand. This presence at the conference signifies an opportunity for investor interaction and potential business growth.
Read more →SNYRSynergy CHC Reports its Seventh Consecutive Quarter of Profitability and its Third Quarter 2024 Financial Results
Synergy CHC Corp. reported its third quarter financial results for 2024, marking its seventh consecutive quarter of profitability. Although revenue decreased by 34% year-over-year primarily due to de-inventorying related to the rebranding of FOCUSfactor products, the company has expanded its retail partnerships, significantly increasing its distribution. Synergy also successfully completed its IPO, enhancing liquidity for future growth initiatives despite facing challenges such as a decrease in gross margin and fluctuations in operating performance.
Read more →SNYRSynergy CHC Corp. Announces Third Quarter 2024 Earnings and Conference Call Information
Synergy CHC Corp. announced the upcoming release of its financial results for the third quarter of 2024, scheduled for December 6, 2024. The company will conduct a conference call featuring its CEO and CFO after the earnings report, allowing investors to engage directly. Synergy is known for its consumer health care products, notably the FOCUSfactor and Flat Tummy brands, which contribute to its market presence.
Read more →SNYRSynergy CHC Corp. Announces Closing of Initial Public Offering
Synergy CHC Corp. successfully completed its initial public offering, issuing 1,150,000 shares at $9.00 each, which began trading on the Nasdaq Global Market under ticker symbol 'SNYR' on October 23, 2024. The company raised approximately $8.4 million in net proceeds, primarily aimed at repaying debts and financing general corporate activities. Roth Capital Partners managed the offering, which was officially registered with the SEC. Despite the positive outcome, the company acknowledged various risks and uncertainties associated with its future projections.
Read more →SNYR▲ +278.2%on this newsshared move
Synergy CHC Corp. Prices $10.35 Million Initial Public Offering
Synergy CHC Corp. has announced the pricing of its initial public offering (IPO) of 1,150,000 shares at $9.00 per share, which will commence trading on the Nasdaq under the ticker 'SNYR' starting October 23, 2024. The offering is expected to close on October 24, 2024, with net proceeds anticipated to be around $8.4 million, which will be utilized for repaying related party promissory notes and general corporate purposes. Roth Capital Partners is acting as the sole manager for the offering.
Read more →SNYRSynergy Announces Intention to Deregister and Terminate Reporting Obligations.
WESTBROOK, ME, June 30, 2020 (GLOBE NEWSWIRE) -- Synergy CHC Corp (OTCM: SNYR) (the “Company”), a consumer healthcare company, intends to file a Form 15 with the SEC to voluntarily effect the deregistration of its Common Stock. Upon the filing of the Form 15, the Company’s obliga
Read more →SNYRSynergy CHC Corp. Announces First Quarter 2020 Results
Westbrook, Maine, June 29, 2020 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the quarter ended March 31, 2020. 2020 First Quarter Highlights Net sales for the first three mo
Read more →SNYRSynergy CHC Corp. Announces Fiscal 2019 Year End Results
Westbrook, Maine, April 29, 2020 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the fiscal year ended December 31, 2019. Generated net cash provided by operating activities of
Read more →SNYRSynergy CHC Corp. Announces Third Quarter 2019 Results
Westbrook, Maine, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the quarter ended September 30th, 2019. 2019 Third Quarter Highlights Generated net cash provide
Read more →SNYRSynergy CHC Corp. Announces Second Quarter 2019 Results
Westbrook, Maine, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the quarter ended June 30th, 2019. 2019 Second Quarter Highlights Generated adjusted EBITDA of $
Read more →SNYRSynergy CHC Corp. Announces First Quarter 2019 Results
Westbrook, Maine, May 03, 2019 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the quarter ended March 31, 2019. 2019 First Quarter Highlights Generated adjusted EBITDA of 2.3
Read more →SNYRSynergy CHC Corp. Announces Fiscal 2018 Year End Results
Westbrook, Maine, March 29, 2019 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the fiscal year ended December 31, 2018. Net sales for the fiscal year ended December 31, 2018 w
Read more →SNYRSynergy CHC Corp. Announces Insider Buying Westbrook, Maine, December 10th, 2018 - Synergy CHC Corp. (OTCQB: SNYR ) ("Synergy" or the "Company"), a consumer health care & beauty company, announced today that Synergy's CE
CHC Corp. Announces Insider Buying Maine, December 10th, 2018- Synergy CHC Corp. (OTCQB: SNYR) ("Synergy" or the "Company"), a consumer health care & beauty company, announced today that Synergy's CEO and Chairman, Jack Ross via his holding company, Gowan Capital Inc has made
Read more →SNYRSynergy CHC Corp. Announces Insider Buying
Westbrook, Maine, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, announced today that Synergy’s CEO and Chairman, Jack Ross via his holding company, Gowan Capital Inc has made a purchase of
Read more →SNYRSynergy CHC Corp. Announces Third Quarter 2018 Results
Westbrook, Maine, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the quarter ended September 30th, 2018. Net sales for the third quarter were $9.2 million, compar
Read more →SNYRSynergy CHC Corp. Announces Canadian Retail Expansion
Westbrook, Maine, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, today announced a major expansion into the Canadian marketplace. Synergy is very pleased to announce it has signed multiple
Read more →SNYRSynergy CHC Corp. Announces Expansion into Mexico
Westbrook, Maine, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, today announced its first expansion into the Mexican marketplace. Synergy is very pleased to announce it has signed a deal w
Read more →SNYRSynergy CHC Corp. Announces Second Quarter 2018 Results
Westbrook, Maine, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the quarter ended June 30, 2018. Net sales for the second quarter were $9.7 million, compared to
Read more →SNYRSynergy CHC Corp. Announces First Quarter 2018 Results
Westbrook, Maine, May 15, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the quarter ended March 31, 2018. Net sales for the first quarter were $9.7 million, compared to
Read more →SNYRSynergy CHC Corp. Announces Fiscal 2017 Year End Results
Westbrook, Maine, April 02, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the fiscal year ended December 31, 2017. Fiscal 2017 Highlights: Launched The Synergy Effect, a
Read more →SNYRSynergy CHC Corp. to Present at 30th Annual Roth Conference on March 13th
Westbrook, Maine, March 05, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR), a leading omni-channel consumer health and beauty company, announced today that Jeffrey Kadanoff, Chief Financial Officer, is scheduled to present at the 30th Annual ROTH conference on Tuesday,
Read more →SNYRSynergy CHC Corp. Announces Third Quarter 2017 Results
Westbrook, Maine, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, reported results for the quarter ended September 30, 2017. Quarter 3 2017 and Recent Highlights: Secured $10 million of fun
Read more →SNYREMBARGOED FOR USE BEFORE Contact: After 8:00pm (Eastern) Jack Ross, Chairman / CEO
EMBARGOED FOR USE BEFORE Contact: After 8:00pm (Eastern) Jack Ross, Chairman / CEO October 19, 2017 Synergy CHC Corp Jack@synergychc.com 615-939-9004 CHC Corp. Hires Patrick McCullough as President Maine, October 19, 2017- Synergy CHC Corp (OTCQB: SNYR), a consumer health ca
Read more →SNYRSynergy CHC Corp. Hires Patrick McCullough as President
Westbrook, Maine, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Synergy CHC Corp (OTCQB:SNYR), a consumer health care & beauty company, announces the appointment of Patrick McCullough to its management team as President. Mr. McCullough’s appointment is an exciting addition to our organizati
Read more →SNYRSynergy CHC Corp. Announces Jeffrey Kadanoff Joins as CFO
Westbrook, Maine, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Synergy CHC Corp (“Synergy”) (OTCQB: SNYR), a consumer health care & beauty company, announces the appointment of Jeffrey Kadanoff as its Chief Financial Officer effective November 1, 2017. Mr. Kadanoff’s appointment strengthen
Read more →SNYREMBARGOED FOR USE BEFORE Contact: After 5:30pm (Eastern) Jack Ross, Chairman / CEO
EMBARGOED FOR USE BEFORE Contact: After 5:30pm (Eastern) Jack Ross, Chairman / CEO October 12, 2017 Synergy CHC Corp Jack@synergychc.com 615-939-9004 CHC Corp. Announces Gale Bensussen joins its Board of Directors Maine, October 12, 2017- Synergy CHC Corp (OTCQB: SNYR), a con
Read more →SNYRSynergy CHC Corp. Announces Gale Bensussen joins its Board of Directors
Westbrook, Maine, Oct. 11, 2017 (GLOBE NEWSWIRE) -- Synergy CHC Corp (OTCQB: SNYR), a consumer health care & beauty company, announces the appointment of Gale Bensussen to its Board of Directors. Mr. Bensussen’s appointment expands the Board to 4 directors, 3 of whom are indepen
Read more →SNYRSynergy CHC Corp. Announces Second Quarter 2017 Results
WESTBROOK, ME--(Marketwired - Aug 14, 2017) - Synergy CHC Corp (OTCQB: SNYR), a consumer health care & beauty company, today reported results for the quarter ended June 30, 2017. Net sales for the second quarter were $9.3 million, compared to $8.2 million for the same quarter in
Read more →SNYRSynergy CHC Corp. Hires Robin Mendenhall to Lead Sales of its Beauty Brand Portfolio
WESTBROOK, ME--(Marketwired - Aug 11, 2017) - Synergy CHC Corp. (OTCQB: SNYR), a consumer health care & beauty company, today announces that Robin Mendenhall has joined Synergy as Vice President of Sales - Beauty. This role is a key addition to our management team that will be re
Read more →SNYREMBARGOED FOR USE BEFORE Contact: After 8am (Eastern) Jack Ross, Chairman / CEO
EMBARGOED FOR USE BEFORE Contact: After 8am (Eastern) Jack Ross, Chairman / CEO August 10, 2017 Synergy CHC Corp Jack@synergychc.com 615-939-9004 CHC Corp. Secures up to US$30 Million of Growth Capital Maine, August 10, 2017- Synergy CHC Corp (OTCQB: SNYR), a consumer health
Read more →SNYRSynergy CHC Corp. Secures up to US$30 Million of Growth Capital
WESTBROOK, ME--(Marketwired - Aug 10, 2017) - Synergy CHC Corp (OTCQB: SNYR), a consumer health care & beauty company, today announced it has received an additional secured loan from Knight Therapeutics Inc. (TSX: GUD) of US$10million. The funds will be used for product acquisiti
Read more →SNYRSynergy CHC Corp. Accelerates growth with Opening of Tech Centre in Los Angeles
WESTBROOK, ME--(Marketwired - Jun 27, 2017) - Synergy CHC Corp. (OTCQB: SNYR), a consumer health care & wellness company, today announced it will open a new tech center for its digital arm, The Synergy Effect, in Culver City, Los Angeles, to accommodate its rapid growth and lever
Read more →SNYRSynergy CHC Corp. Acquires "Per-fekt Beauty Brand" expanding its presence in the cosmetics and skincare space
WESTBROOK, ME--(Marketwired - Jun 22, 2017) - Synergy CHC Corp (OTCQB: SNYR), a consumer health care company, today announced it has entered into and simultaneously closed on an Asset Purchase Agreement with Per-fekt Beauty Holdings LLC and CDG Holdings, LLC, which owns 92.3% of
Read more →SNYRSynergy CHC Corp. Announces Private Placement Offering of up to US$20 Million
WESTBROOK, ME--(Marketwired - May 3, 2017) - Synergy CHC Corp. ("Synergy" or the "Company") (OTCQB: SNYR) is pleased to announce that it has entered into an agreement with Mackie Research Capital Corporation (the "Agent" or "MRCC") for a best-efforts private placement offering (t
Read more →SNYRSynergy CHC Corp. Announces First Quarter 2017 Results
WESTBROOK, ME--(Marketwired - May 1, 2017) - Synergy CHC Corp (OTCQB: SNYR) today reported results for the quarter ended March 31, 2017. Net sales for the first quarter were $10.8 million, compared to $8.3 million for the same quarter in 2016, a 30% increase. For the first quart
Read more →SNYRSynergy CHC Corp. re-launches FOCUSfactor online with exclusive new product line, new website and major TV campaign
WESTBROOK, ME--(Marketwired - Apr 18, 2017) - Synergy CHC Corp (OTCQB: SNYR) has officially re-launched its online presence, with a new website providing consumers a direct purchasing method right at their fingertips. The re-launch coincides with the release of much-anticipated p
Read more →SNYRSynergy CHC Corp. launches digital arm, The Synergy Effect, the ultimate growth and innovation platform online
WESTBROOK, ME--(Marketwired - Apr 11, 2017) - Synergy CHC Corp (OTCQB: SNYR) has officially launched The Synergy Effect, its ROI innovation engine and online marketing platform, built to drive online revenue growth for all of its brands. On the back of several successful acquisi
Read more →SNYRSynergy CHC Corp. launches new brand, Sneaky Vaunt(R), and sets the new growth benchmark since online launch via Synergy's growth platform
WESTBROOK, ME--(Marketwired - Apr 4, 2017) - Synergy CHC Corp (OTCQB: SNYR) has launched its newest brand, Sneaky Vaunt and has set a new growth benchmark. After a number of successful acquisitions in 2015 and extraordinary organic growth in 2016, Synergy has begun 2017 strongly
Read more →SNYRSynergy CHC Corp Announces Fiscal 2016 Year End Results
WESTBROOK, ME--(Marketwired - Mar 27, 2017) - Synergy CHC Corp (OTCQB: SNYR) today reported results for the year ended December 31, 2016. Net sales for the fiscal year ended December 31, 2016 were $34.8 million, compared to $13.5 million for fiscal year 2015, a 158% increase. Fo
Read more →SNYRSynergy CHC Corp creates deeper Partnership with Knight Therapeutics
WESTBROOK, ME--(Marketwired - Jan 4, 2017) - Synergy CHC Corp ("Synergy") (OTCQB: SNYR) and Knight Therapeutics Inc. (TSX: GUD) announced as of December 23rd that, ("Knight"), through one of its wholly-owned subsidiaries has committed to invest up to US $2 million as a lead order
Read more →SNYRSynergy CHC Corp Announces Third Quarter 2016 Earnings Release
WESTBROOK, ME--(Marketwired - Oct 27, 2016) - Synergy CHC Corp (OTCQB: SNYR) today reported results for the quarter ended September 30, 2016. Net sales for the third quarter of 2016 were $11.6 million, compared to $3.2 million for the same quarter of 2015. For the third quarter
Read more →SNYRSynergy CHC Corp Announces Second Quarter 2016 Earnings Release
WESTBROOK, ME--(Marketwired - Aug 10, 2016) - Synergy CHC Corp (OTCQB: SNYR) today reported results for the quarter ended June 30, 2016. Net sales for the second quarter were $8.3 million, compared to $2.5 million for the same quarter of 2015. For the second quarter, net loss wa
Read more →SNYRSynergy CHC Corp Announces First Quarter 2016 Earnings Release
WESTBROOK, ME--(Marketwired - Apr 25, 2016) - Synergy CHC Corp (OTCQB: SNYR) today reported results for the quarter ended March 31, 2016. Jack Ross, chairman and chief executive officer, commented, "We are very pleased to release these results, as this is the first time we are s
Read more →SNYREMBARGOED FOR USE BEFORE Contact: After 9am (Eastern) Jack Ross, Chairman / CEO
EMBARGOED FOR USE BEFORE Contact: After 9am (Eastern) Jack Ross, Chairman / CEO November 16, 2015 Synergy CHC Corp Jack@synergychc.com 615-939-9004 CHC Corp Acquires Another Quality Brand in "UrgentRx" Maine, November 16, 2015 - Synergy CHC Corp (OTCQB: SNYR) a consumer healt
Read more →SNYRSynergy CHC Corp Acquires "Flat Tummy Tea," an Australian Company With Significant Social Media Presence
WESTBROOK, ME--(Marketwired - Nov 16, 2015) - Synergy CHC Corp (OTCQB: SNYR), a consumer health care company, today announced it has acquired a 100% ownership stake in Nomad Choice PTY LTD, an Australian company who owns the brand Flat Tummy Tea, which has significant social medi
Read more →SNYRSynergy CHC Corp Acquires Another Quality Brand in "UrgentRx"
WESTBROOK, ME--(Marketwired - Nov 16, 2015) - Synergy CHC Corp (OTCQB: SNYR) a consumer health care company, today announced it has acquired a 100% ownership stake in Breakthough Products, Inc. (UrgentRx). UrgentRx is engaged in the business of developing and selling medications
Read more →SNYRSynergy CHC Corp. Names Al Baumeler EVP Sales & Marketing (Retail)
WESTBROOK, ME--(Marketwired - Aug 20, 2015) - Synergy CHC Corp. (OTCQB: SNYR), a company that markets and distributes consumer products primarily in the health and wellness industry, today announces that Al Baumeler has been named EVP Sales & Marketing (Retail). Based on the comp
Read more →SNYRSynergy CHC Corp Acquires Anti-Aging Business From Hand MD Corp(R)
WESTBROOK, ME--(Marketwired - Aug 19, 2015) - Synergy CHC Corp (OTCQB: SNYR), a consumer health care company, today announced it has acquired a 50% ownership stake in Hand MD Corp and has secured the global exclusive sales, marketing & distribution rights for all channels for thi
Read more →SNYREMBARGOED FOR USE BEFORE Contact: After 5pm (Eastern) Jack Ross, Chairman / CEO
EMBARGOED FOR USE BEFORE Contact: After 5pm (Eastern) Jack Ross, Chairman / CEO July 1, 2015 Synergy Strips Jack@synergystrips.com 615-939-9004 Strips Corp Does another Acquisition with the Purchase of U.S Rights For Neuragen July 1, 2015 - Synergy Strips Corp (OTCQB: SNYR) a
Read more →SNYRJack Ross, Chairman / CEO Synergy Strips Jack@synergystrips.com 615-939-9004 Synergy Strips Corp. Acquires Assets of America's No.1 Brain Health Supplement, FOCUSfactor SANTA MONICA, CA (
Contact: Jack Ross, Chairman / CEO Synergy Strips Jack@synergystrips.com 615-939-9004 Strips Corp. Acquires Assets of America's No.1 Health Supplement, FOCUSfactor MONICA, CA (January 26, 2015) -Synergy Strips Corp. (OTCQB:SNYR) ("Synergy"), a company that markets and distrib
Read more →SNYRSee accompanying notes to unaudited condensed
SYNERGY STRIPS CORP. FINANCIAL STATEMENTS Condensed Balance Sheets as of March 31, 2014 (Unaudited) and December 31, 2013 F-2 Condensed Statement of Operations for the three months ended March 31, 2014 and 2013 (Unaudited) F-3 Condensed Statement of Cash Flows for the three mon
Read more →SNYRSYNERGY STRIPS CORP. FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2013 AND 2012 TABLE OF CONTENTS Page Report of Independent Registered Public Accounting Firm F-1 Balance Sheets F-2 Statements of Operations F-3 S
SYNERGY STRIPS CORP. FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2013 AND 2012 Page Report of Independent Registered Public Accounting Firm F-1 Balance Sheets F-2 Statements of Operations F-3 Statement of Stockholders' Deficit F-4 Statements of Cash Flows F-5 Notes to
Read more →Competitive Position
How SNYR ranks across every disease it competes inCompetitive Position is a premium feature
See how SNYR ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial